Approvals/TGA/LUCENTIS ranibizumab (rbe) 1.65 mg/0.165 mL solution for injection prefilled syringe

Approved

STANDARD

LUCENTIS ranibizumab (rbe) 1.65 mg/0.165 mL solution for injection prefilled syringe

Approval Id: 2b82027f81a33527
Product Name: LUCENTIS ranibizumab (rbe) 1.65 mg/0.165 mL solution for injection prefilled syringe
Artg Id: 212387
Artg Name: LUCENTIS ranibizumab (rbe)1.65 mg/0.165 mL solution for injection prefilled syringe
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2013-11-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/81261cdc97e6e5f483af59e5c4c48e23.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/21ee801642d6bf4d4565f233d7e7409a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

2b82027f81a33527

Type

Standard